InvestorsHub Logo
Followers 14
Posts 406
Boards Moderated 0
Alias Born 01/21/2022

Re: None

Thursday, 02/03/2022 8:22:58 PM

Thursday, February 03, 2022 8:22:58 PM

Post# of 113917
Quick math question. Since this is all about the science, let's assume adva-27a is successful in phase 1 human trials.

Let's also assume that the result of this financing with warrants slightly more than doubles the outstanding share count.

Am I better off with 8% of a company worth 25 million or 3.75% of a company worth $5 billion dollars? Maybe some of the experts can help me with that math.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SBFM News